trending Market Intelligence /marketintelligence/en/news-insights/trending/ea0bscfh5mgthm10c6q4sq2 content esgSubNav
In This List

OncoCyte names COO

Blog

Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns

Blog

Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders

Blog

Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps


OncoCyte names COO

Alameda, Calif.-based OncoCyte Corp. appointed Albert Parker as COO.

Previously, Parker served as the managing shareholder of GC Legal Advisors. He has also served as executive vice president, general counsel and corporate secretary at Sunovion Pharmaceuticals Inc.

OncoCyte is a biotechnology company and focuses on developing non-invasive blood and urine diagnostic tests for the early detection of cancer.